PROPEL BIO MANAGEMENT, LLC
PROPEL BIO MANAGEMENT, LLC is a Seed, Series A and Series C+ fund in the US investing in Healthcare and biotechnology.
- Stages
- Seed, Series A, Series C+
- Sectors
- Healthcare, biotechnology
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2022
- Assets under management
- $247.5M
- Website
- propelbio.com
Check size not disclosed
Thesis
Propel Bio Management, LLC, operating as Propel Bio Partners, is a venture capital firm founded in 2022 and based in Los Angeles, California. With $247.5 million in AUM, the firm invests in biosciences businesses, particularly in biotechnology and healthcare, aiming to advance human health by supporting disruptive therapies and technologies. Their strategy involves a hybrid hedge fund and venture capital approach, targeting early-stage companies (Seed and Series A) and supporting them through clinical development to commercialization. Propel Bio Partners emphasizes building ecosystems around founders by providing financial backing, operational expertise, strategic guidance, and global network access. The firm also has a Medical and Investment Advisory Board.
Common questions
Does PROPEL BIO MANAGEMENT, LLC invest at the Seed stage?
Yes. PROPEL BIO MANAGEMENT, LLC lists Seed, Series A and Series C+ among the stages it invests in.
Where does PROPEL BIO MANAGEMENT, LLC invest?
PROPEL BIO MANAGEMENT, LLC invests in the US.